IGF1 and sarcopenia: A systematic review of biomarkers in patients with hip fractures identified decreased IGF-1 concentrations as one of the characteristic changes in individuals with sarcopenia, making IGF-1 a potential component of biomarker panels for the clinical assessment of muscle function [105].